IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Study: Oral solid-dosage form excipients market growing at 7.4%/year

5:47 AM MDT | May 6, 2014 | Deepti Ramesh

The oral solid-dosage form (OSDF) excipients market, which is valued at nearly $2.3 billion in the United States, Europe, India, and China, is growing sustainably on a global scale, according to recently published report by consulting and research firm Kline & Co. In the emerging Indian and Chinese markets, rising incomes and willingness to spend more on health care are driving the growth in the consumption of excipients. Key factors driving growth in major markets, like the United States and Europe, include the aging populations and high demand for...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa